Highlights
NASDAQ: INFI       Infinity Pharmaceuti
Last Price Today's Change   Day's Range   Trading Volume
1.24   -0.01 (0.80%)  1.24 - 1.29  49,000

Overview

 
Avg Volume (4 weeks):126,836
4 Weeks Range:0.88 - 1.31
4 Weeks Price Volatility (%):
83.72%
52 Weeks Range:0.82 - 1.95
52 Weeks Price Volatility (%):
37.17%
Average Price Target: 20.00
Price Target Upside/Downside: +18.76

Headlines



No recent Headlines for this stock.


Business Background

Infinity is a clinical-stage biopharmaceutical company focused on developing novel medicines for the treatment of specific cancers. The company's developed products, and those under development, include therapies targeting hematologic malignancies, or blood cancers; refractory indolent non-Hodgkin lymphoma; refractory chronic lymphocytic leukemia; and solid tumors, including melanoma and non-small cell lung cancer. Infinity has a strategic partnership with AbbVie to develop some of its oncology-related treatments.

  Be the first to like this.
 


 

4706  3347  638  230 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 GDX 26.97-0.65 
 CHK 0.76+0.041 
 EEM 43.07+0.25 
 BAC 33.67+0.58 
 GE 11.10+0.31 
 SPY 314.87+2.85 
 XOP 21.23+0.74 
 VIAB 24.22+0.75 
 ONTX 0.35+0.058 
Partners & Brokers